Frontal lobe in vivo 31P-MRS reveals gender differences in healthy controls, not in schizophrenics

NMR in Biomedicine

Volumn 12, Issue 8, 1999, Pages 483-489

  Riehemann, Stefan ^a   Volz, Hans Peter ^a   Wenda, Berit ^a   Hübner, Gabriele ^a   Rößger, Grit ^a   Rzanny, Reinhard ^a   Sauer, Heinrich ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Frontal lobe; Gender; Phosphorus magnetic resonance spectroscopy; Schizophrenia

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHLORPROMAZINE; CREATINE KINASE; CREATINE PHOSPHATE; PHOSPHOLIPID; PHOSPHORUS;

ADULT; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; FRONTAL LOBE; HIGH ENERGY PHOSPHATE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE;

ADENOSINE TRIPHOSPHATE; ADULT; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOCREATINE; SCHIZOPHRENIA; SEX CHARACTERISTICS;

EID: 0033376002     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199912)12:8<483::AID-NBM589>3.0.CO;2-D     Document Type: Article

References (33)

1. Pettegrew J. W., Keshavan M. S., Panchalingam K., Strychor S., Kaplan D. B., Tretta M. G. and Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Arch. Gen. Psychiat. 48, 563-568 (1991).
2. Williamson P., Drost D., Stanley J., Carr T., Morrison S. and Merskey H. Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. Arch. Gen. Psychiat. 48, 578 (1991).
3. 31P magnetic resonance chemical shift imaging. Acta Psychiat. Scand. 86, 455-462 (1992).
4. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biol. Psychiat. 36, 503-510 (1994).
5. 31P-MR spectroscopy study. Schizophren. Res. 13, 209-215 (1994).
6. Kato T., Shiori T., Murashita J., Hamakawa H., Inubushi T. and Takahashi S. Lateralized abnormalities of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiat. Res. Neuroimag. 61, 151-160 (1995).
7. Shiori T., Kato T., Inubushi T., Murashita J. and Takahashi S. Correlation of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negatives symptoms in schizophrenia. Psychiat. Res. 55, 223-235 (1995).
8. Stanley J. A., Williamson P. C., Drost D. J., Carr T. J., Rylett J., Malla A. and Thomson R. T. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch. Gen. Psychiat. 52, 399-406 (1995).
9. George T. P. and Spence M. W. Alterations of membrane phospholipid metabolism in patients with schizophrenia assessed by phosphorus magnetic resonance spectroscopy. Arch. Gen. Psychiat. 53, 1065-1066 (1996).
10. 31P magnetic resonance spectroscopy studies in schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 55, 115-118 (1996).
11. Hinsberger A. D., Williamson P. C., Carr T. J., Stanley J. A., Drost D. J., Densmore M., MacFabe G. C. and Montemurro D. G. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia. J. Psychiat. Neurosci. 22, 111-117 (1997).
12. 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique - preliminary results. Biol. Psychiat. 41, 644-648 (1997).
13. 31P-magnetoresonance-spectroscopic study. Psychiat. Res. 76, 123-129 (1997).
14. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal cortex in schizophrenics - a study including 50 patients and 36 controls. Biol. Psychiat. 44, (in press) (1998).
15. 31P magnetic resonance spectroscopy of normal peripubertal children: effects of sex and frontooccipetal location. Proceedings of the 5th ISMRM Scientific Meeting, Vancouver, Canada 1408 (1997).
16. Baxter L. R., Mazziotta J. C., Phelps M. E., Selin C. E., Guze B. H. and Fair banks L. Cerebral glucose metabolic rates in normal human females versus normal males. Psychiat. Res. 21, 237-245 (1987).
17. Anderason P. J., Zametkin A. J., Guo A. C., Baldwin P. and Cohen R. M. Gender related differences in regional cerebral glucose metabolism in normal volunteers. Psychiat. Res. 51, 175-183 (1994).
18. 31P magnetic resonance spectroscopy. J. Cereb. Blood Flow Metab. 12, 584-592 (1992).
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third revised edition, American Psychiatric Press, Washington, DC (1987).
20. Ordige R. R., Connelly A. and Lohman J. A. Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J. Magn. Reson. Imag. 66, 283-294 (1986).
21. Rudin M. and Sauter A. In vivo phosphorus-31 NMR: potential and limitations. In: In-Vivo Magnetic Resonance Spectroscopy III: In-Vivo MR Spectroscopy: Potential and Limitations (M. Rudin, ed.), 28 of NMR Basic Principles and Progress, Springer, Berlin, 161-188 (1992).
22. 13C enriched metabolites from cell suspensions incubated in deuterated media. Magn. Reson. Med. 36, 359-365 (1996).
23. http://www.uku.fi/perch.html
24. 31Phosphorus NMR spectroscopy in schizophrenia - the influence of different evaluation methods on spectral interpretation. Proceedings of the 4th International Conference on Functional Mapping of the Human Brain published as a Supplement to NeuroImage, Vol. 7 No. 4, Montreal, Canada S621 (1998).
25. 31P NMR spectra of the human brain - a comparison of different approaches for clinical applications. Radiology (submitted).
26. 31P nuclear magnetic resonance spectroscopy. Neurology 35, 781-788 (1985).
27. Yoshii F., Barker W. W., Chang J. Y., Loewenstein D., Apicella A., Smith D., Boothe T., Ginsberg M. D., Pascal S. and Duara R. Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. J. Cereb. Blood Flow Metab. 8, 654-661 (1988).
28. Azari N. P., Pettegrew K. D., Pietrini P., Murphy D. G., Horowitz B. and Schapiro M. B. Sex differences in patterns of hemispheric cerebral metabolism: a multiple regression/discriminant analysis of positron emission tomographic data. Int. J. Neurosci. 81, 1-20 (1995).
29. Esposito G., Van Horn J. D., Weinberger D. R. and Berman K. F. Gender differences in cerebral blood flow as a function of cognitive state with PET. J. Nucl. Med. 37, 559-564 (1996).
30. Bortz J. Statistik, Springer, Berlin, 250 (1993).
31. Häfner H., Maurer K., Loffler W., Fatkenheuer B., an der Heiden W., Riecher-Rossler A., Behrens S. and Gattaz W. F. The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br. J. Psychiat. (Suppl.) 23, 29-38 (1994).
32. de Beer R. Lecture notes, Quantitative in vivo NMR, University of Technology Delft, The Netherlands, 1994. http://dutnsic.tn.tudelft.nl:8080/c59\_to\_html/c59.html.
33. van den Boogaart A. The use of signal processing algorithms to obtain biochemically relevant parameters from magnetic resonance data sets. Ph.D. thesis, University of London, 1995.